Download PDF
Nuklearmedizin 2011; 50(06): N64-N65
DOI: 10.1055/s-0037-1621652
Case report
Schattauer GmbH

Unexpected only pulmonary manifestation of sarcoidosis

B. Bodmann
1   Department of Internal Medicine and Pneumonology, Wilhelminenspital Wien and Medical University of Vienna
,
V. Havranek
1   Department of Internal Medicine and Pneumonology, Wilhelminenspital Wien and Medical University of Vienna
,
M. Kneussl
1   Department of Internal Medicine and Pneumonology, Wilhelminenspital Wien and Medical University of Vienna
,
J. Czernin
2   Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at the University of California Los Angeles, USA
,
P. Knoll
3   Department of Nuclear Medicine with PET-center, Wilhelminen spital Wien and Medical University of Vienna, Austria
,
S. Mirzaei
3   Department of Nuclear Medicine with PET-center, Wilhelminen spital Wien and Medical University of Vienna, Austria
› Author Affiliations
Further Information

Publication History

received: 26 April 2011

accepted in revised form: 31 May 2011

Publication Date:
09 January 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Aide N, Benayoun M, Kerrou K. et al. Impact of 18F-fluorodeoxyglucose imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by 18F-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol 2007; 80: e67-e71.
    CrossrefPubMedSearch in Google Scholar
  • 2 Basu S, Yadav M, Joshi JM. et al. Active pre-treatment pure pulmonary parenchymal sarcoidosis with raised serum angiotensin converting enzyme level: characteristics on PET with glucose metab- olism and cell proliferation tracers and HRCT. Eur J Nucl Med Mol Imaging. 2011
    CrossrefPubMedSearch in Google Scholar
  • 3 DeRemee RA. The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest 1983; 83: 128-133.
    CrossrefPubMedSearch in Google Scholar
  • 4 James D, Thompson A. The course of sarcoidosis and its modification by treatment. Lancet 1959; 1: 1057-1061.
    PubMedSearch in Google Scholar
  • 5 Keijsers RG, Grutters JC, van Velzen-Blad H. et al. 18F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis. Eur J Nucl Med Mol Imaging 2010; 37: 1181-1188.
    CrossrefPubMedSearch in Google Scholar
  • 6 Lannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-2165.
    CrossrefPubMedSearch in Google Scholar
  • 7 Prager E, Wehrschuetz M, Bisail B. et al. Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging. Nuklearmedizin 2008; 47: 18-23.
    Thieme ConnectPubMedSearch in Google Scholar
  • 8 Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961; 2: 1165-1172.
    CrossrefPubMedSearch in Google Scholar
  • 9 Teirstein AS, Machac J, Almeida O. et al. Results of 188 whole-body fluoro deoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007; 132: 1949-1953.
    CrossrefPubMedSearch in Google Scholar
  • 10 Xiu Y, Yu JQ, Cheng E. et al. Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. Clin Nucl Med 2005; 30: 193-195.
    CrossrefPubMedSearch in Google Scholar